Imperial Innovations invests in Cambridge

25th Aug 2011 16:46

Technology investment group, Imperial Innovations, said it was pumping £1.3m into new Cambridge drug development firm Mission Therapeutics. The investment is part of a £6m funding round at Mission, which will focus on oncology. The deal will leave Imperial with 15.7% equity in the firm. In Decembe

Read more

Year of disappointments for IPSO Ventures

19th Aug 2011 11:24

Shares in IPSO Ventures tumbled to a new low after the technology commercialisation group posted a pre-tax loss in the year to 30 April amid "challenging" trading. IPSO exploits innovations developed by researchers in universities and other institutions. Pre-tax profits losses narrowed to £424,000

Read more

Imperial Innovations strengthens its balance sheet

19th Apr 2011 17:05

Imperial Innovations Group, the technology commercialisation and investment group, saw pre-tax profit jump to £1.3m, from £0.1m, in the half year ended 31 January 2011. The firm raised £140m in new equity during the period to increase investment in selected companies established in conjunction with

Read more

SABMiller non-exec invests £104,000

3rd Feb 2011 16:36

John Manser, who has been a non-executive director of SABMiller for a decade has bought 5,000 shares in the brewer. Manser paid 2083.82p a share for the 5,000 shares, which cost a total of £104,000. He has taken advantage of the weakness in the share price since the beginning of 2011. Organic vo

Read more

Thursday tips round-up: Renishaw, RSA, Cookson

27th Jan 2011 06:31

Niche engineer Renishaw's halfway statement to January 26 yesterday was full of superlatives. First-half revenues were 26% higher than their previous high point and pre-tax profits were 132% higher. Numis Securities calculates £72.2m in profits this year against less than £30m last time, which puts

Read more

Drax director buys

9th Dec 2010 16:17

Drax non-executive director Tony Thorne has bought £28,000 worth of shares in the power generator. He has paid 378.69p a share for 7,500 shares. Thorne was appointed to the board in June and these are the first shares he has bought. Thorne is a former chief executive of paper company DS Smith.

Read more

Imperial Innovations raises £140m to target more universities

7th Dec 2010 16:16

Technology commercialisation outfit Imperial Innovations is raising £140m to invest in companies founded in Imperial College and other top British universities. It is raising the money by issuing two new shares for every three existing shares at 350p a share. The money will be used to accelerate

Read more

Small caps round-up: Orosur Mining, Imperial Innovations...

12th Oct 2010 11:50

Orosur Mining had a "good" first quarter as an increase in production to the upper end of expectations aided a swing to profit for the three months ended August 31. The company reported net income of $3.5m compared with a loss of $2.2m a year ago as output hit 12,937 ounces of gold and the average

Read more

Thursday's tips round-up: Imperial Innovations, Barratt, Autonomy

10th Jun 2010 07:42

Imperial Innovations is starting to make strong gains on exits from its portfolio, selling Thiakis, the developer of an anti-obesity drug, to America's Wyeth and, last week, disposing of Respivert, the maker of a respiratory treatment, to an offshoot of Johnson & Johnson. At 474½p, tuck away. The I

Read more

Small caps round-up: Globo, Imperial Innovations, Discover Leisure

27th Jan 2010 09:55

Telecommunications software group Globo's shares surged after it said it would be providing its CitronGo! platform that allows users of devices to access their e-mail and other services to a Southeast Asian mobile operator with more than 85m subscribers. Imperial Innovations, which commercialises t

Read more

Genus non-exec bulks up stake

20th May 2009 16:59

Professor Barry Furr, a non-executive director at the animal breeding technology group Genus, has spent £30,000 more than doubling his stake in the animal breeding company, the firm confirmed today. He bought 5,000 shares at 600p a time and now has 8,000. Furr, a former chief scientist for the dru

Read more